From: Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital
Type 2 Diabetes | First Teleconsultation | Last teleconsultation | p value | n |
---|---|---|---|---|
Glycosylated hemoglobin, %* | ||||
< 6 months | 6.7 (6.3–7.2) | 6.6 (6.1–7.3) | 0.353 | 67 |
≥ 6 months | 6.6 (6.1–7.3) | 6.5 (6-7.4) | 0.858 | 189 |
LDL cholesterol, mg/dL* | ||||
< 6 months | 87 (61–111) | 81 (59–101) | 0.242 | 45 |
≥ 6 months | 80.5 (59–112) | 76.8 (57.5–100) | 0.053 | 148 |
HDL cholesterol, mg/dL* | ||||
< 6 months | 42.5 (38–50) | 42.5 (38–50) | 0.688 | 42 |
≥ 6 months | 46 (38–53) | 46 (37–53) | 0.135 | 133 |
Triglycerides, mg/dL* | ||||
< 6 months | 141 (117–211) | 134 (106–173) | 0.317 | 47 |
≥ 6 months | 142.5 (106-191.5) | 135.5 (90.5–166) | < 0.001 | 144 |
Creatinine, mg/dL* | ||||
< 6 months | 0.95 (0.715–1.16) | 0.915 (0.74–1.24) | 0.981 | 44 |
≥ 6 months | 0.84 (0.71–1.07) | 0.89 (0.76–1.08) | < 0.001 | 131 |
Microalbuminuria, mg/L* | ||||
< 6 months | 6.9 (5.2–11) | 5.4 (4.4–13.8) | 0.678 | 9 |
≥ 6 months | 13.5 (7.6–43) | 15 (7.15-60) | 0.269 | 32 |